Healthy Volunteers Sought for Upcoming Trial of New Investigational AIDS Vaccine in New York City
3 Jan 2005

2004

IAVI statement on 2004 HIV/AIDS statistics: New technologies key to prevention.
23 Nov 2004

Crucell signs agreement with IAVI to develop AdVac vector for AIDS vaccine program
12 Nov 2004

Crucell Grants IAVI Exclusive License to use AdVac's Technology for AIDS Vaccine
14 Sept 2004

Senior PR Executive Ellena Friedman Joins IAVI as Vice President of Communications
9 Sept 2004

Global response to AIDS must include a preventive vaccine
2 Sept 2004

Statement on DNA.HIVA and MVA.HIVA preventive AIDS vaccine candidates
30 Aug 2004

IAVI: progress toward an AIDS vaccine outweighed by challenges
12 July 2004

New Options Needed to Prevent the Spread of HIV/AIDS
24 June 2004

IAVI applauds G8 support for an AIDS vaccine
9 June 2004

On World AIDS Vaccine Day, progress and challenges
18 May 2004

International development expert Robert Hecht to join IAVI
23 Feb 2004

Germany begins its first AIDS vaccine trial, partnering with IAVI
16 Feb 2004

Volunteers sought for AIDS vaccine trial in Amsterdam
6 Feb 2004

World-class AIDS vaccine researcher Emilio Emini joins IAVI
13 Jan 2004

2003 

PhRMA report: industry steps up AIDS vaccine and drug research
5 Dec 2003

Targeted Genetics, IAVI, CCRI begin human trial of vaccine candidate to prevent HIV/AIDS
9 Dec 2003

Trial of New Investigational AIDS Vaccine Begins in New York and Rochester
8 Dec 2003

IAVI begins AIDS vaccine trials in South Africa, Switzerland
12 Nov 2003

Thai trial confirms earlier results that VaxGen's AIDSVAX is not efficacious-IAVI response
12 Nov 2003

IAVI hails start of AIDS vaccine testing in South Africa
3 Nov 2003

South Africa approves IAVI sponsored AIDS vaccine candidate for human trials
25 Aug 2003

IAVI hails start of trial in South Africa and US to test AlphaVax's AIDS vaccine
30 July 2003 

Statement of IAVI's Seth Berkley on Merck and Aventis partnering to test an AIDS vaccine
26 Mar 2003

IAVI continues collaboration with Targeted Genetics Corp. to develop rAAV AIDS vaccine
25 Mar 2003

Statement of IAVI's Seth Berkley regarding the results on VaxGen's AIDSVAX
24 Feb 2003

AIDS Vaccine Trial Begins in Entebbe, Uganda
10 Feb 2003

2002

Statement of IAVI's Seth Berkley, MD, in response to the latest UN HIV/AIDS statistics
26 Nov 2002 

US government starts trial of new AIDS vaccine tailored for multiple subtypes of the virus 
13 Nov 2002

Anticipating the results of the AIDSVAX efficacy trial 
14 Oct 2002

IAVI calls Barcelona AIDS 2002 'a reality check' for vaccines, treatment
11 July 2002

IAVI outlines new,intensive R&D agenda to fast-track promising AIDS vaccine candidates to final-stage human testing
9 July 2002 

IAVI launches Neutralizing Antibody Consortium to accelerate search for preventive AIDS vaccine
9 July 2002

IAVI Applauds Thailand's Leadership in HIV Vaccine Search 
8 July 2002

US: Kerry-Frist proposed legislation would boost US spending on global HIV/AIDS prevention and treatment 
15 May 2002

Sweden's Bioption, IAVI partnering to develop globally accessible AIDS vaccines 
6 May 2002

Global AIDS Fund makes first grants: US$600 million to prevention and treatment programs worldwide
25 April 2002

Pair of IAVI-sponsored AIDS vaccines for Africa shows promise in initial human trials, progresses to intermediate testing in UK
4 April 2002

US government announces plans for final stage human trial of ALVAC-AIDSVAX in Thailand
28 Feb 2002

Merck releases promising data from early human studies of two AIDS vaccines
28 Feb 2002

Advocates seek jump in funding to develop anti-HIV microbicides by 2007
14 Feb 2002

World Leaders Address Dual Challenges of an AIDS Vaccine
4 Feb 2002

Berna Biotech teams with IAVI, Gallo lab, Uganda
to test AIDS vaccine designed for developing countries
4 Feb 2002

Results from Harvard University study underscore need for more AIDS vaccine research
22 Jan 2002